BELLE Michigan, LP
VC Fund
Troy, United States
BELLE Michigan, LP is a VC fund in Troy focused on Software and Medical. The BELLE Michigan Fund, LP is an early stage investment fund building great companies in Michigan, the Midwest, and other regions. We provide a premier source of human and financial capital to women-led companies. We look for capital-efficient enterprises with a unique product or service that fill an urgent market need.BELLE Michigan partnersbelieve human capital is just as valuable as financial capital. We seek investments in high growth, capital efficient and scalable enterprises that welcome our expertise and insight, and seek to leverage our leadership and experience. We seek high net worth investors, who are new to early stage investing, and provide them with the opportunity to engage with our portfolio companies. BELLE Michigan targets investments in technology-enabled services, life sciences/medical devices, mobile/internet/IT, advanced manufacturing and CleanTech market sectors. We invest in companies who have female leadership or commit to recruiting women to the C-suite and Board of Directors. We seek teams with strong domain expertise, and proven commercialization and entrepreneurial experience.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 50%
- Fund size:
- $465k
- Last fund:
Last updated:
For AI agents: llms.txt
Industries BELLE Michigan, LP invests in
Stages BELLE Michigan, LP invests in
Countries BELLE Michigan, LP invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
Terese Hunwick
|
|||
|
|
|||
2 more contacts available
Investment Focus
Industry
- Software 3 (25%)
- Medical 2 (17%)
- Health Care 2 (17%)
- Manufacturing 2 (17%)
- SaaS 1 (8%)
Stage
- Seed 5 (42%)
- Series A 2 (17%)
- Series B 1 (8%)
- Convertible Note 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Nancy Philippart
General Partner & Co-Founder
|
General Partner & Co-Founder | Total investments: 3 | Find email | |
|
Terese Hunwick
General Partner
|
General Partner | Total investments: 0 | Find email | |
|
Carolyn Cassin
Founder and General Partner
|
Founder and General Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Ulendo provides software to improve the speed and accuracy of advanced manufacturing machines such as 3D printers and robots. The company's first product, Ulendo VC (vibration compensation), doubles the speed of extrusion-based 3D printers without sacrificing quality. Using its patented algorithm, Ulendo enhances a printer's firmware toanticipate vibration and change the tool path in order to avoid the quality issues that result from vibration. The company is also applying a similar vibration compensation approach to address vibration in industrial thereby enabling them to operate at faster speeds and with heavier payloads. This product, Ulendo VC-R, will be launched in 2025. The company recently launched Ulendo Calibration-as-a-ServiceTM, a hosted subscription-based software platform that calibrates an extrusion-based printer within seconds, thereby avoiding the current time-consuming practice of printing and measuring parts to determine the appropriate printing parameters. The company's third product, Ulendo HC (heat compensation), uses a patent-pending algorithm to optimize the laser path of a metal laser powder bed fusion (LPBF) printer to significantly reduce deformation and stress in the printed part. | $505K / Seed / Dec 21, 2022 | |
|
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | $5M / Seed / Aug 16, 2022 | |
|
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | $5M / Seed / Aug 16, 2022 | |
|
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | Seed / Dec 01, 2021 | |
|
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | Seed / Dec 01, 2021 | |
|
|
Sisu Global Health provides clinically proven, patented, high margin devices, starting with Hemafuse, a highly effective alternative to donor blood. With a simple push and pull of a handle, the device transfers blood from where it is pooled in internal bleeding to a blood bag: blood is salvaged and immediately re-transfused. Sisu achievedregulatory approval in Ghana and Kenya and Hemafuse and signed two distribution contracts.Founded in 2014 by Carolyn Yarina, Gillian Henker, and Katie Kirsch, Sisu Global Health is headquartered in Baltimore, Maryland. | $1.2M / Convertible Note / Sep 14, 2018 | |
|
|
It’s never been easier to display and manage your commercial inventory online. Work Truck Solutions handles all the heavy lifting so you can focus on selling more commercial vehicles. | $5M / Series B / Jun 29, 2017 | |
|
|
Court Innovations, a Software-as-a-Service company, develops an online case resolution platform. It offers Matterhorn, an online platform that enables users to select their court, search for case, check the status, get updates, and resolve it online. Court Innovations' platform also allows courts to handle many high-volume infractions onlinethat save citizens and courts time and money, enables decision-makers to resolve cases equitably, and empowers defendants to work with the court to resolve minor violations informally and at a convenient time. It serves customers in Michigan and Ohio. J.J. Prescott founded Court Innovations in 2014. It has its headquarters in Ann Arbor in Michigan. | $1.8M / Series A / Jun 06, 2017 | |
|
|
Consortia Health Clinical Continence Services offer a powerful combination of the most advanced testing systems and highly trained technicians to help you diagnose and treat incontinence right in your office. | $2.6M / Seed / May 19, 2017 | |
|
|
Sisu Global Health provides clinically proven, patented, high margin devices, starting with Hemafuse, a highly effective alternative to donor blood. With a simple push and pull of a handle, the device transfers blood from where it is pooled in internal bleeding to a blood bag: blood is salvaged and immediately re-transfused. Sisu achievedregulatory approval in Ghana and Kenya and Hemafuse and signed two distribution contracts.Founded in 2014 by Carolyn Yarina, Gillian Henker, and Katie Kirsch, Sisu Global Health is headquartered in Baltimore, Maryland. | $1.1M / Seed / Sep 07, 2016 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BELLE Michigan, LP invest in?
BELLE Michigan, LP invests primarily in Software, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BELLE Michigan, LP?
Public channels for BELLE Michigan, LP include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BELLE Michigan, LP?
The team at BELLE Michigan, LP includes Nancy Philippart (General Partner & Co-Founder), Terese Hunwick (General Partner) and Carolyn Cassin (Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!